Its announcement will come about the heels of the same licensing arrangement made available in February to Adastra Labs, which had until now focused on crafting cannabis extracts. Adastra's license also allows it to make and provide psilocybin and psilocin – hallucinogens far more normally often known as magic mushrooms that create effects compar